Home / Markets / News / MNC pharma in focus; Merck, Novartis India, GSK Pharma hit 52-week highs

MNC pharma in focus; Merck, Novartis India, GSK Pharma hit 52-week highs

Novartis India, Merck, GSK Pharma, Pfizer and Sanfoi India have rallied by up to 13% on the BSE in intra-day trade.

Premium

Novartis is addressing the pricing question with a new type of agreement: For patients whose care is covered by the US govt programmes, the company will only get paid if patients show signs that the treatment is working within a month | Photo: istock

SI Reporter Mumbai

Last Updated : Aug 08 2018 | 1:01 PM IST

Shares of multinational (MNC) pharmaceutical companies have rallied by up to 13%, hitting their respective 52-week highs on the BSE in intra-day trade on Wednesday after reporting a strong financial result for the quarter ended June 2018.

Novartis India (up 13% at Rs 734), Merck (up 5% at Rs 3,030), GlaxoSmithKline (GSK) Pharmaceuticals (up 2% at Rs 3,339) were trading at their respective 52-week highs, while Pfizer (up 5% at Rs 2,794) and Sanfoi India (up 1% at Rs 6,215) were quoting close to their 52-week highs on the BSE. On comparison, the S&P BSE Sensex was up 0.47%

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in